Physician profile
Tara Sweeney
NPI 1457929846
$1,790.35
in general payments reported to CMS, 2019-2025
10 companies · $445 in 2025
The $445 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.19 · 2022: $361 · 2023: $635 · 2024: $312 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,391.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $566.99 | 2022-2025 | Advance Xp, Ams 700, General - Kidney Stone Disease |
| Procept Biorobotics Corporation | $346.11 | 2023-2025 | Aquabeam Robotic System |
| Coloplast Corp | $147.94 | 2021-2023 | Titan |
| Calyxo, INC. | $144.42 | 2025 | Cvac Aspiration System |
| Medtronic, INC. | $135.43 | 2023-2024 | Interstim |
| Urogen Pharma, INC. | $124.89 | 2022 | |
| Ambu INC. | $103.38 | 2024 | |
| Axonics, INC. | $88.57 | 2022-2023 | Axonics |
| Abbvie INC. | $79.18 | 2024 | |
| Teleflex LLC | $53.44 | 2022-2025 | Deflux Metal Needle |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.